MSS/ MMRp
Quiénes somos
Safety, Tolerability, and Immunogenicity of mRNA-4157 Alone in Participants With Resected Solid Tumors and in Combination With Pembrolizumab in Participants With Unresectable Solid Tumors
A Phase II Trial Assessing Nivolumab in Class II Expressing Microsatellite Stable Colorectal Cancer
Estudio para probar diferentes dosis de BI 1823911 solo y combinado con otros medicamentos en personas con diferentes tipos de cáncer avanzado con mutación KRAS.
Un estudio de fase Ib/IIa de CR6086 en combinación con balstilimab en pacientes con cáncer colorrectal metastásico pMMR-MSS
PIPAC para el tratamiento de las metástasis colorrectales peritoneales
Biweekly Intraperitoneal Oxaliplatin With Systemic Capecitabine and Bevacizumab for Patients With Peritoneal Carcinomatosis From Appendiceal or Colorectal Cancer
A Study of LGK974 in Patients With Malignancies Dependent on Wnt Ligands
Tolerability and Safety of Vemurafenib, Cetuximab Combined With Camrelizumab for BRAF V600E-mutated /MSS Metastatic Colorectal Cancer
A Study of CC-95251, a Monoclonal Antibody Directed Against SIRPα, in Participants With Advanced Solid and Hematologic Cancers
A Study of a Personalized Neoantigen Vaccine in Combination With Immune Checkpoint Blockade for Patients With Metastatic Colorectal Cancer
